Physician profile
Robert Chen
NPI 1447241484
$15,441.05
in general payments reported to CMS, 2019-2025
46 companies · $53.28 in 2025
The $53.28 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,402 · 2020: $1,530 · 2021: $4,162 · 2022: $2,968 · 2023: $2,325 · 2025: $53.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,067 · Travel and Lodging: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,067.41 |
| Travel and Lodging | $311.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,846.07 | 2021-2023 | Intellis Adaptivestim |
| Nevro Corp. | $1,753.04 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $1,677.59 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $1,057.24 | 2019-2023 | Xtampza |
| Abbott Laboratories | $988.75 | 2019-2023 | Octrode, Proclaim |
| Abbvie INC. | $932.07 | 2021-2023 | Ubrelvy, Qulipta |
| Medtronic USA, INC. | $762.19 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $761.44 | 2019-2023 | Relistor |
| Teva Pharmaceuticals USA, INC. | $758.70 | 2019-2023 | Ajovy |
| Amgen INC. | $708.08 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $703.04 | 2022 | |
| Scilex Pharmaceuticals INC. | $405.84 | 2019-2023 | Ztlido |
| Boston Scientific Corporation | $397.39 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Redhill Biopharma INC. | $278.60 | 2020-2021 | |
| Pfizer INC. | $254.04 | 2019-2023 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.